Early onset of effect following galcanezumab treatment in patients with previous preventive medication failures
{{output}}
Background: Galcanezumab is a monoclonal antibody (mAb) that binds calcitonin gene-related peptide (CGRP) and is indicated for the preventive treatment of migraine. Galcanezumab demonstrated early onset of effect in patients with... ...
